Longitudinal Study on Patients with Irritable Bowel Syndrome: Epidemiological Monitoring and Cost FRESH-PEF8715-en Jean-Marc SABATE Longitudinal Study on Patients with Irritable Bowel Syndrome: Epidemiological Monitoring and Cost SECSII FRESH-PEF8715-en 8715 FRESH-PEF8715 Jean-Marc SABATE ASSOCIATION NATIONALE DES HEPATO-GASTROENTEROLOGUES DES HOPITAUX GENERAUX DE FRANCE ASS DES PATIENTS SOUFFRANTS DU SYNDROME DE L INTESTIN IRRITABLE (APSSII) GROUPE FRANCAIS DE NEURO-GASTRO-ENTEROLOGIE (GFNG) CLUB REFLEXION GROUPES DE GASTRO ENTEROL (CREGG) SOCIETE NATIONALE FRANÇAISE DE GASTRO-ENTEROLOGIE Epidemiology France Portal (PEF) SOCIETE NATIONALE FRANÇAISE DE GASTRO-ENTEROLOGIE null Jean-Marc;SABATE irritable bowel syndrome abdominal pain altered bowel habits direct cost indirect cost severity diagnosis treatment Gastroenterology Irritable bowel syndrome Healthcare system determinants: Use of care Socio-demographic and economic determinants Behavioral determinants: Eating habits Healthcare system determinants Behavioral determinants Irritable bowel syndrome (IBS), which involves abdominal pain and altered bowel habits, is a common disease that affects 5% of the population. There is no diagnostic test provided and the treatments used are often ineffective. IBS may significantly reduce quality of life and impact daily activities and work. All of these factors can contribute to increased consultations and treatment and, as such, the overall cost of the disease in France for which there is no recent data. The aim of this cohort is to describe the actual overall cost of IBS by assessing direct costs (examinations, consultations, hospitalisations, reimbursed or non-reimbursed treatment, self-medication, alternative treatments), and indirect costs (work disruption, reduced productivity), assessing the role of factors linked to the disease (IBS type, severity, disease history) and the treatment type (centres of expertise, hospital, practice). This is a multicentric French cohort of IBS patients for carrying out health economics and epidemiological analyses (increased knowledge of prognostic demographic factors, history, comorbidities, predominant symptoms, type of treatment). null France Individuals Patients population Male Female Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Aged (65 to 79 years) Aged 18 to 75 years old; - Suffering from IBS (ROME-II criteria); - Normal digestive examinations (total colonoscopy and/or normal barium enema for subjects aged 50 or over, proctosigmoidoscopy and/or normal barium enema in people under 50 years old). These examinations should be carried out 5 years prior to enrolment for patients over 50 years old. There is no time limit for patients under 50 years of age. - Satisfactory level of French language comprehension and expression. - Internet access or agreement to send questionnaires by post. Clinical data Participant-reported health data Real-time monitoring with CRA. Health event/morbidity Health care consumption and services Quality of life/health perception Other < 500 individuals Other Observational Study Observational Study 500 Unknown Restricted access Contact the scientist in charge for further information. Access on specific project only